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fungal pathogens could be isolated
from sputum by classic and molecular
methods. After 4–5 days, his tempera-
ture was 40°C, a productive cough
with dyspnea was noted, and his con-
dition deteriorated. Achest radiograph
showed progression of the infiltrates,
and a computed tomography scan of
the abdomen and chest showed infil-
trates near the pleura, suggesting
encapsulated fluid (Figure). An ultra-
sound-guided lung biopsy was per-
formed, and mucoid material was
aspirated. Microscopy and a culture
from the aspirate showed a cryptococ-
cal isolate. This isolate was further
identified by internal transcribed
spacer and D1/D2 sequencing, as well
as amplified fragment-length poly-
morphism analysis (2). In addition,
detailed genotyping was performed
by using sequences of 7 genes (IGS,
CAP10, GPD1, LAC1, MPD1, PLB1,
and  TEF1; GenBank accession nos.
DQ861593–DQ861599) (5).
Extensive molecular research
showed that this isolate belonged to
the highly virulent AFLPgenotype 6A
(VGIIa) of Cryptococcus gattii, which
is the major genotype involved in the
Vancouver Island C. gattii outbreak
(1–4). All 7 sequenced genes had a
complete match with the sequence
types specific for isolates involved in
the Vancouver Island outbreak (5).
Thus, we conclude that the pathogen
was acquired during the patient’s visit
to Vancouver Island and imported to
Denmark. The presence of 3 crypto-
coccal masses of more or less equal
size suggests that the patient was
exposed to a high concentration of
infectious cells of C. gattii. The
observed incubation time of 6 weeks
is shorter than that was previously
reported for infections related to the
Vancouver Island outbreak (2–11 mo)
(4). These observations, in combina-
tion with the absence of any known
predisposing factor in this patient,
such as smoking or treatment with
corticosteroids, suggest that this spe-
cific AFLP6 genotype of C. gattii is
highly virulent (4,5).
This case suggests a potential risk
of tourists acquiring cryptococcosis
while visiting Vancouver Island.
Therefore, we recommend tourists
and medical staff of healthcare centers
worldwide be alert for symptoms of
cryptococcosis after travel to
Vancouver Island.
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Clostridium difficile
in Discharged
Inpatients,
Germany
To the Editor: Using discharge
diagnoses from US hospitals in
2000–2003, McDonald et al. recently
documented a dramatic increase in the
rate of Clostridium difficile–associat-
ed disease (CDAD) (1). During the
same period, a new strain of C. diffi-
cile was identified; this strain appears
more virulent, at least in part because
it produces higher levels of toxin (2). 
To our knowledge, this strain has
not been identified in Germany.
However, to address this emerging
threat, we conducted a similar analy-
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Figure. A) Chest radiograph and B) computed tomographic scan of the patient showing 3
nodular Cryptococcus gattii infiltrates near pleura.LETTERS
sis of discharge data to compare find-
ings from the United States with data
from Germany. We therefore deter-
mined the absolute number of inpa-
tient discharges from all hospitals in
Germany with the number of dis-
charge diagnoses of CDAD reported
in the national Statistische Bundesamt
for the years 2000–2004. We then cal-
culated the incidence of CDAD as a
discharge diagnosis for each year and
stratified our results by age groups
(Figure). 
Our results confirm the observa-
tions from the United States. The
effect of C. difficile on illness of
patients in hospitals in Germany has
escalated dramatically. This is true
especially for patients >60 years of
age. This trend indicates the need for
increased awareness of this pathogen
and a concerted effort to control
CDAD by reducing unnecessary
antimicrobial drug use and imple-
menting currently recommended
infection control measures. It also
highlights the need to develop more
rapid and accurate diagnostic tools
and more effective prevention and
treatment strategies.
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Human Bocavirus
in Febrile Children,
the Netherlands 
To the Editor: Human bocavirus
(HBoV) is a recently discovered virus
of the family Parvoviridae, genus
Bocavirus, which appears to cause
widespread respiratory tract infec-
tions (RTI) in children. In selected
groups of children with RTI, detection
rates have varied from 2.8% to 11.3%
(1–9). However, the exact prevalence
and pathogenic effects of this virus
remain to be established.
During a prospective cohort
study to evaluate the prognosis of
fever at a general practice after-hours
service in Rotterdam, nasopharyngeal
swabs were collected from febrile
children and tested for respiratory
viruses, including HBoV. We report
the incidence and clinical features of
HBoV infection in these children.
From June 1, 2005, through
January 16, 2006, all children 3
months to 6 years of age whose par-
ents contacted the after-hours service
because of fever, as reported by par-
ents and not further defined, were eli-
gible for inclusion in the study.
Children were excluded when the par-
ents could not communicate in Dutch
(n = 77) and if the child had already
been included within the past 2 weeks
(n = 11). A research nurse visited the
child at home within 24 hours of
inclusion. The child was physically
examined, and a nasopharyngeal swab
and a blood sample for C-reactive
protein measurement were collected.
The parents subsequently recorded
the child’s symptoms in a diary for 7
days. The Central Committee on
Research Involving Human Subjects,
the Netherlands, approved this study.
Nucleic acids were isolated on a
MagnaPure isolation station (Roche
Applied Science, Penzberg, Germany)
and subsequently analyzed by real-
time assays. Detection of HBoV was
performed by using a primers set and a
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Figure. Incidence of Clostridium difficile–associated disease per 100,000 inpatients upon
discharge from hospitals in Germany.